Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03650348
Title PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
UCLA Health Santa Monica California 90404 United States Details
Ochsner Cancer Institute New Orleans Louisiana 70121 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43202 United States Details
M.D. Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78240 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field